{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:42:27Z","timestamp":1792698147904,"version":"4.5.0"},"reference-count":90,"publisher":"Walter de Gruyter GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Metabolically healthy obesity (MHO) is a heterogeneous phenotype characterized by preserved traditional metabolic markers despite excess adiposity. However, accumulating evidence suggests that MHO may not be uniformly benign and may confer increased long-term cardiovascular risk through inflammatory and adipose tissue\u2013mediated mechanisms. This narrative review synthesizes contemporary evidence on cardiovascular risk in MHO, focusing on visceral adiposity, ectopic fat, and immune metabolic pathways. Literature published between January 2010 and December 2025 was identified through PubMed\/MEDLINE, Embase, Web of Science, and Cochrane Library. Across the reviewed evidence, MHO is frequently associated with the progression to metabolically unhealthy obesity, although transition rates and cardiovascular risk estimates vary according to MHO definitions. Visceral and ectopic fat are associated with subclinical atherosclerosis, coronary calcification, and cardiovascular events, including in individuals without overt metabolic abnormalities. Evidence regarding heart failure and ventricular dysfunction remains limited and inconsistent. Low-grade inflammation and adipose immune remodeling, including NLRP3 inflammasome activation, provide plausible mechanisms, although human evidence remains predominantly observational. Key gaps include inconsistent MHO definitions, limited longitudinal imaging and biomarker integration, population diversity, and lack of validated MHO-specific risk models. Standardized phenotyping and prospective validation of inflammation-based risk stratification are required.<\/jats:p>","DOI":"10.1515\/jbcpp-2026-0266","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:02:10Z","timestamp":1792695730000},"source":"Crossref","is-referenced-by-count":0,"title":["The cardiovascular risk of metabolically healthy obesity: an inflammatory perspective"],"prefix":"10.1515","author":[{"given":"Jimena","family":"Lozano-N\u00fa\u00f1ez","sequence":"first","affiliation":[{"name":"Faculty of Medicine , National University of Cajamarca , Cajamarca , Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adithya","family":"Lakshmi","sequence":"additional","affiliation":[{"name":"Our Lady of Fatima University , Valenzuela , Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binsu Ann","family":"Benny","sequence":"additional","affiliation":[{"name":"Yenepoya Medical College , Mangalore , Karnataka , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashasti","family":"Sharma","sequence":"additional","affiliation":[{"name":"Shri Padmavati Medical College for Women, SVIMS , Tirupati , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Jayakumar","sequence":"additional","affiliation":[{"name":"Kerala University of Health Sciences , Tiruvalla , Kerala , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3695-0732","authenticated-orcid":false,"given":"N.L.","family":"Swathi","sequence":"additional","affiliation":[{"name":"Manipal College of Nursing, Manipal Academy of Higher Education , Manipal , Karnataka , India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_001","doi-asserted-by":"crossref","unstructured":"Eckel, N, Meidtner, K, Kalle-Uhlmann, T, Stefan, N, Schulze, MB. Metabolically healthy obesity and cardiovascular events: a systematic review and meta-analysis. Eur J Prev Cardiol 2016;23:956\u201366. https:\/\/doi.org\/10.1177\/2047487315623884.","DOI":"10.1177\/2047487315623884"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_002","doi-asserted-by":"crossref","unstructured":"Cheng, D, Zhao, X, Yang, S, Cui, H, Wang, G. Metabolomic signature between metabolically healthy overweight\/obese and metabolically unhealthy overweight\/obese: a systematic review. DMSO 2021;14:991\u20131010. https:\/\/doi.org\/10.2147\/DMSO.S294894.","DOI":"10.2147\/DMSO.S294894"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_003","doi-asserted-by":"crossref","unstructured":"Yeh, T-L, Chen, H-H, Tsai, S-Y, Lin, C-Y, Liu, S-J, Chien, K-L. The relationship between metabolically healthy obesity and the risk of cardiovascular disease: a systematic review and meta-analysis. JCM 2019;8:1228. https:\/\/doi.org\/10.3390\/jcm8081228.","DOI":"10.3390\/jcm8081228"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_004","doi-asserted-by":"crossref","unstructured":"Bagheri, M, Djazayery, A, Qi, L, Yekaninejad, MS, Chamari, M, Naderi, M, et al.. Effectiveness of vitamin D therapy in improving metabolomic biomarkers in obesity phenotypes: two randomized clinical trials. Int J Obes 2018;42:1782\u201396. https:\/\/doi.org\/10.1038\/s41366-018-0107-0.","DOI":"10.1038\/s41366-018-0107-0"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_005","doi-asserted-by":"crossref","unstructured":"Hashimoto, Y, Hamaguchi, M, Tanaka, M, Obora, A, Kojima, T, Fukui, M. Metabolically healthy obesity without fatty liver and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies. Obes Res Clin Pract 2018;12:4\u201315. https:\/\/doi.org\/10.1016\/j.orcp.2017.12.003.","DOI":"10.1016\/j.orcp.2017.12.003"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_006","doi-asserted-by":"crossref","unstructured":"Karelis, AD, Faraj, M, Bastard, J-P, St-Pierre, DH, Brochu, M, Prud\u2019homme, D, et al.. The metabolically healthy but obese individual presents a favorable inflammation profile. J\u00a0Clin Endocrinol Metab 2005;90:4145\u201350. https:\/\/doi.org\/10.1210\/jc.2005-0482.","DOI":"10.1210\/jc.2005-0482"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_007","doi-asserted-by":"crossref","unstructured":"Wildman, RP, Muntner, P, Reynolds, K, McGinn, AP, Rajpathak, S, Wylie-Rosett, J, et al.. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999\u20132004). Arch Intern Med 2008;168:1617\u201324. https:\/\/doi.org\/10.1001\/archinte.168.15.1617.","DOI":"10.1001\/archinte.168.15.1617"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_008","doi-asserted-by":"crossref","unstructured":"Huang, M-Y, Wang, M-Y, Lin, Y-S, Lin, C-J, Lo, K, Chang, I-J, et al.. The association between metabolically healthy obesity, cardiovascular disease, and all-cause mortality risk in Asia: a systematic review and meta-analysis. Int J Environ Res Publ Health 2020;17:1320. https:\/\/doi.org\/10.3390\/ijerph17041320.","DOI":"10.3390\/ijerph17041320"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_009","doi-asserted-by":"crossref","unstructured":"Gao, J-W, You, S, Liu, Z-Y, Hao, Q-Y, Wang, J-F, Vuitton, DA, et al.. Different metabolic phenotypes of obesity and risk of coronary artery calcium progression and incident cardiovascular disease events: the CARDIA study. ATVB 2022;42:677\u201388. https:\/\/doi.org\/10.1161\/ATVBAHA.122.317526.","DOI":"10.1161\/ATVBAHA.122.317526"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_010","doi-asserted-by":"crossref","unstructured":"Cho, YK, Lee, J, Kim, HS, Park, J, Lee, WJ, Kim, Y, et al.. Metabolic health is a determining factor for incident colorectal cancer in the obese population: a nationwide population-based cohort study. Cancer Med 2021;10:220\u20139. https:\/\/doi.org\/10.1002\/cam4.3607.","DOI":"10.1002\/cam4.3607"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_011","doi-asserted-by":"crossref","unstructured":"Hsueh, Y, Yeh, T-L, Lin, C-Y, Tsai, S-Y, Liu, S-J, Lin, C-M, et al.. Association of metabolically healthy obesity and elevated risk of coronary artery calcification: a systematic review and meta-analysis. PeerJ 2020;8:e8815. https:\/\/doi.org\/10.7717\/peerj.8815.","DOI":"10.7717\/peerj.8815"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_012","doi-asserted-by":"crossref","unstructured":"Silva, LCA, Dalboni, MA, Elias, RM. Extracellular mass to body cell mass ratio in patients on peritoneal dialysis. Clin Nutr 2020;326:39. https:\/\/doi.org\/10.1016\/j.clnu.2019.10.006.","DOI":"10.1016\/j.clnu.2019.10.006"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_013","doi-asserted-by":"crossref","unstructured":"Mirzababaei, A, Djafarian, K, Mozafari, H, Shab-Bidar, S. The long-term prognosis of heart diseases for different metabolic phenotypes: a systematic review and meta-analysis of prospective cohort studies. Endocrine 2019;63:439\u201362. https:\/\/doi.org\/10.1007\/s12020-019-01840-0.","DOI":"10.1007\/s12020-019-01840-0"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_014","doi-asserted-by":"crossref","unstructured":"Sezgin, Y, \u00c7o\u015fkun, S, Aslan, Y, \u015eim\u015fek, S, Kaya, S. Evaluation of the relationship between body composition measurements and metabolic syndrome severity score in obese individuals. Medicine 2025;104:e41943. https:\/\/doi.org\/10.1097\/MD.0000000000041943.","DOI":"10.1097\/MD.0000000000041943"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_015","doi-asserted-by":"crossref","unstructured":"Alizadeh, S, Esmaeili, H, Alizadeh, M, Daneshzad, E, Sharifi, L, Radfar, H, et al.. Metabolic phenotypes of obese, overweight, and normal weight individuals and risk of chronic kidney disease: a systematic review and meta-analysis. Arch Endocrinol Metab 2019;63:427\u201337. https:\/\/doi.org\/10.20945\/2359-3997000000149.","DOI":"10.20945\/2359-3997000000149"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_016","doi-asserted-by":"crossref","unstructured":"Andrade, S, Morais, T, Sandovici, I, Seabra, AL, Const\u00e2ncia, M, Monteiro, MP. Adipose tissue epigenetic profile in obesity-related dysglycemia\u00a0\u2013\u00a0a systematic review. Front Endocrinol 2021;12:681649. https:\/\/doi.org\/10.3389\/fendo.2021.681649.","DOI":"10.3389\/fendo.2021.681649"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_017","doi-asserted-by":"crossref","unstructured":"Cheng, Y, Han, J, Li, Q, Shi, Y, Zhong, F, Wu, Y, et al.. Metabolic obesity phenotypes: a friend or foe of digestive polyps? An observational study based on National Inpatient Database. Metabolism 2022;132:155201. https:\/\/doi.org\/10.1016\/j.metabol.2022.155201.","DOI":"10.1016\/j.metabol.2022.155201"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_018","doi-asserted-by":"crossref","unstructured":"Goodarzi, MO, Rotter, JI. Genetics insights in the relationship between type 2 diabetes and coronary heart disease. Circ Res 2020;126:1526\u201348. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.316065.","DOI":"10.1161\/CIRCRESAHA.119.316065"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_019","doi-asserted-by":"crossref","unstructured":"Meng, M, Guo, Y, Kuang, Z, Liu, L, Cai, Y, Ni, X. Risk of stroke among different metabolic obesity phenotypes: a systematic review and meta-analysis. Front Cardiovasc Med 2022;9:844550. https:\/\/doi.org\/10.3389\/fcvm.2022.844550.","DOI":"10.3389\/fcvm.2022.844550"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_020","doi-asserted-by":"crossref","unstructured":"Putra, ICS, Kamarullah, W, Prameswari, HS, Pramudyo, M, Iqbal, M, Achmad, C, et al.. Metabolically unhealthy phenotype in normal weight population and risk of mortality and major adverse cardiac events: a meta-analysis of 41 prospective cohort studies. Diabetes & metabolic syndrome. Clin Res Rev 2022;16:102635. https:\/\/doi.org\/10.1016\/j.dsx.2022.102635.","DOI":"10.1016\/j.dsx.2022.102635"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_021","doi-asserted-by":"crossref","unstructured":"Valizadeh, M, Ahmadi, AR, Abbaspour, F, Valizadeh, A, Syed Hasani, AH, Moteshakereh, SM, et al.. The risk of kidney dysfunction in metabolically healthy\/unhealthy population with normal weight or overweight\/obesity: a systematic review and meta-analysis. Eat Weight Disord 2024;69:29. https:\/\/doi.org\/10.1007\/s40519-024-01697-x.","DOI":"10.1007\/s40519-024-01697-x"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_022","doi-asserted-by":"crossref","unstructured":"Yang, C, Liu, X, Dang, Y, Li, J, Jing, J, Tian, D, et al.. Obesity metabolic phenotype, changes in time and risk of diabetes mellitus in an observational prospective study on general population. Int J Publ Health 2022;67:1604986. https:\/\/doi.org\/10.3389\/ijph.2022.1604986.","DOI":"10.3389\/ijph.2022.1604986"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_023","doi-asserted-by":"crossref","unstructured":"Abiri, B, Koohi, F, Ebadinejad, A, Valizadeh, M, Hosseinpanah, F. Transition from metabolically healthy to unhealthy overweight\/obesity and risk of cardiovascular disease incidence: a systematic review and meta-analysis. Nutr Metabol Cardiovasc Dis 2022;32:2041\u201351. https:\/\/doi.org\/10.1016\/j.numecd.2022.06.010.","DOI":"10.1016\/j.numecd.2022.06.010"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_024","doi-asserted-by":"crossref","unstructured":"Iqbal, J, Wu, H-X, Nawaz, MA, Jiang, H-L, Xu, S-N, Huang, B-L, et al.. Risk of incident chronic kidney disease in metabolically healthy obesity and metabolically unhealthy normal weight: a systematic review and meta-analysis. Obes Rev 2024;25:e13656. https:\/\/doi.org\/10.1111\/obr.13656.","DOI":"10.1111\/obr.13656"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_025","doi-asserted-by":"crossref","unstructured":"Kabat, GC, Wu, WY-Y, Bea, JW, Chen, C, Qi, L, Stefanick, ML, et al.. Metabolic phenotypes of obesity: frequency, correlates and change over time in a cohort of postmenopausal women. Int J Obes 2017;41:170\u20137. https:\/\/doi.org\/10.1038\/ijo.2016.179.","DOI":"10.1038\/ijo.2016.179"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_026","doi-asserted-by":"crossref","unstructured":"Escobar, S, Pe\u00e7anha, D, Duque, M, Duque, A, Crahim, V, De Lorenzo, A, et al.. Evaluation of systemic endothelial-dependent and endothelial-independent microvascular reactivity in metabolically healthy obesity: an observational study. Microvasc Res 2023;148:104553. https:\/\/doi.org\/10.1016\/j.mvr.2023.104553.","DOI":"10.1016\/j.mvr.2023.104553"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_027","doi-asserted-by":"crossref","unstructured":"Su, Z, Efremov, L, Mikolajczyk, R. Differences in the levels of inflammatory markers between metabolically healthy obese and other obesity phenotypes in adults: a systematic review and meta-analysis. Nutr Metabol Cardiovasc Dis 2024;34:251\u201369. https:\/\/doi.org\/10.1016\/j.numecd.2023.09.002.","DOI":"10.1016\/j.numecd.2023.09.002"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_028","doi-asserted-by":"crossref","unstructured":"Ortega, FB, Lee, D, Katzmarzyk, PT, Ruiz, JR, Sui, X, Church, TS, et al.. The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur Heart J 2013;34:389\u201397. https:\/\/doi.org\/10.1093\/eurheartj\/ehs174.","DOI":"10.1093\/eurheartj\/ehs174"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_029","doi-asserted-by":"crossref","unstructured":"Oosterom-Eijmael, MJP, Le Cessie, S, Slats, AM, Hiemstra, PS, Thijs, W, Lamb, HJ, et al.. The relation between visceral fat and lung function in the general population is in part mediated by CRP and leptin. Expert Rev Respir Med 2025;19:887\u201397. https:\/\/doi.org\/10.1080\/17476348.2025.2502557.","DOI":"10.1080\/17476348.2025.2502557"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_030","doi-asserted-by":"crossref","unstructured":"Chen, S, Liu, H, Liu, X, Li, Y, Li, M, Liang, Y, et al.. Central obesity, C-reactive protein and chronic kidney disease: a community-based cross-sectional study in Southern China. Kidney Blood Press Res 2013;37:392\u2013401. https:\/\/doi.org\/10.1159\/000355718.","DOI":"10.1159\/000355718"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_031","doi-asserted-by":"crossref","unstructured":"Buscemi, S, Chiarello, P, Buscemi, C, Corleo, D, Massenti, MF, Barile, AM, et al.. Characterization of metabolically healthy Obese people and metabolically unhealthy normal-weight people in a general population cohort of the ABCD study. J\u00a0Diabetes Res 2017;2017:1\u20139. https:\/\/doi.org\/10.1155\/2017\/9294038.","DOI":"10.1155\/2017\/9294038"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_032","doi-asserted-by":"crossref","unstructured":"Sandsdal, RM, Juhl, CR, Jensen, SBK, Lundgren, JR, Janus, C, Blond, MB, et al.. Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial. Cardiovasc Diabetol 2023;22:41. https:\/\/doi.org\/10.1186\/s12933-023-01765-z.","DOI":"10.1186\/s12933-023-01765-z"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_033","doi-asserted-by":"crossref","unstructured":"Marbou, WJT, Kuete, V. Prevalence of metabolic syndrome and its components in bamboutos division\u2019s adults, west region of Cameroon. BioMed Res Int 2019;2019:1\u201312. https:\/\/doi.org\/10.1155\/2019\/9676984.","DOI":"10.1155\/2019\/9676984"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_034","doi-asserted-by":"crossref","unstructured":"Stelmach-Mardas, M, Walkowiak, J. Dietary interventions and changes in cardio-metabolic parameters in metabolically healthy obese subjects: a systematic review with meta-analysis. Nutrients 2016;8:455. https:\/\/doi.org\/10.3390\/nu8080455.","DOI":"10.3390\/nu8080455"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_035","doi-asserted-by":"crossref","unstructured":"Marra, AM, Arcopinto, M, Salzano, A, Bobbio, E, Milano, S, Misiano, G, et al.. Detectable interleukin-9 plasma levels are associated with impaired cardiopulmonary functional capacity and all-cause mortality in patients with chronic heart failure. Int J Cardiol 2016;209:114\u20137. https:\/\/doi.org\/10.1016\/j.ijcard.2016.02.017.","DOI":"10.1016\/j.ijcard.2016.02.017"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_036","doi-asserted-by":"crossref","unstructured":"Lind, L, Strand, R, Kullberg, J, Ahlstr\u00f6m, H. Cardiovascular-related proteins and the abdominal visceral to subcutaneous adipose tissue ratio. Nutr Metabol Cardiovasc Dis 2021;31:532\u20139. https:\/\/doi.org\/10.1016\/j.numecd.2020.09.010.","DOI":"10.1016\/j.numecd.2020.09.010"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_037","doi-asserted-by":"crossref","unstructured":"Shen, W, Middleton, MS, Cunha, GM, Delgado, TI, Wolfson, T, Gamst, A, et al.. Changes in abdominal adipose tissue depots assessed by MRI correlate with hepatic histologic improvement in non-alcoholic steatohepatitis. J\u00a0Hepatol 2023;78:238\u201346. https:\/\/doi.org\/10.1016\/j.jhep.2022.10.027.","DOI":"10.1016\/j.jhep.2022.10.027"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_038","doi-asserted-by":"crossref","unstructured":"Nowak, KL, Moretti, F, Bussola, N, Steele, CN, Gregory, AV, Kline, TL. Visceral adiposity and progression of ADPKD: a cohort study of patients from the TEMPO 3:4. Trial Am J Kidney Dis 2024;285. https:\/\/doi.org\/10.1053\/j.ajkd.2024.02.014.","DOI":"10.1053\/j.ajkd.2024.02.014"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_039","doi-asserted-by":"crossref","unstructured":"Gepner, Y, Shelef, I, Komy, O, Cohen, N, Schwarzfuchs, D, Bril, N, et al.. The beneficial effects of Mediterranean diet over low-fat diet may be mediated by decreasing hepatic fat content. J\u00a0Hepatol 2019;71:379\u201388. https:\/\/doi.org\/10.1016\/j.jhep.2019.04.013.","DOI":"10.1016\/j.jhep.2019.04.013"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_040","doi-asserted-by":"crossref","unstructured":"Goldenshluger, A, Constantini, K, Goldstein, N, Shelef, I, Schwarzfuchs, D, Zelicha, H, et al.. Effect of dietary strategies on respiratory quotient and its association with clinical parameters and organ fat loss: a randomized controlled trial. Nutrients 2021;13:2230. https:\/\/doi.org\/10.3390\/nu13072230.","DOI":"10.3390\/nu13072230"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_041","doi-asserted-by":"crossref","unstructured":"Bjermo, H, Iggman, D, Kullberg, J, Dahlman, I, Johansson, L, Persson, L, et al.. Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial. Am J Clin Nutr 2012;95:1003\u201312. https:\/\/doi.org\/10.3945\/ajcn.111.030114.","DOI":"10.3945\/ajcn.111.030114"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_042","doi-asserted-by":"crossref","unstructured":"Christensen, RH, Wedell-Neergaard, AS, Lehrskov, LL, Legaard, GE, Dorph, E, Larsen, MK, et al.. Effect of aerobic and resistance exercise on cardiac adipose tissues: secondary analyses from a randomized clinical trial. JAMA Cardiol 2019;4:778. https:\/\/doi.org\/10.1001\/jamacardio.2019.2074.","DOI":"10.1001\/jamacardio.2019.2074"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_043","doi-asserted-by":"crossref","unstructured":"Lee, S, Bacha, F, Hannon, T, Kuk, JL, Boesch, C, Arslanian, S. Effects of aerobic versus resistance exercise without caloric restriction on abdominal fat, intrahepatic lipid, and insulin sensitivity in obese adolescent boys. Diabetes 2012;61:2787\u201395. https:\/\/doi.org\/10.2337\/db12-0214.","DOI":"10.2337\/db12-0214"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_044","doi-asserted-by":"crossref","unstructured":"Anaszewicz, M, Wawrze\u0144czyk, A, Czerniak, B, Bana\u015b, W, Socha, E, Lis, K, et al.. Leptin, adiponectin, tumor necrosis factor \u03b1, and irisin concentrations as factors linking obesity with the risk of atrial fibrillation among inpatients with cardiovascular diseases. Kardiol Pol 2019;77:1055\u201361. https:\/\/doi.org\/10.33963\/kp.14989.","DOI":"10.33963\/KP.14989"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_045","doi-asserted-by":"crossref","unstructured":"Matsuzawa, Y, Funahashi, T, Nakamura, T. The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. J\u00a0Atheroscler Thromb 2011;18:10\u20135551.","DOI":"10.5551\/jat.7922"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_046","doi-asserted-by":"crossref","unstructured":"Yarasheski, KE, Cade, WT, Overton, ET, Mondy, KE, Hubert, S, Laciny, E, et al.. Exercise training augments the peripheral insulin-sensitizing effects of pioglitazone in HIV-infected adults with insulin resistance and central adiposity. Am J Physiol Endocrinol Metab 2011;300:E243\u201351. https:\/\/doi.org\/10.1152\/ajpendo.00468.2010.","DOI":"10.1152\/ajpendo.00468.2010"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_047","doi-asserted-by":"crossref","unstructured":"Suder, A, Makiel, K, Targosz, A, Kosowski, P, Malina, RM. Effects of exercise and dietary interventions on asprosin, leptin, and lipid metabolism in males with abdominal obesity, a randomized controlled trial. Sci Rep 2024;14:28109. https:\/\/doi.org\/10.1038\/s41598-024-79853-7.","DOI":"10.1038\/s41598-024-79853-7"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_048","doi-asserted-by":"crossref","unstructured":"Sj\u00f6gren, P, Sierra-Johnson, J, Kallings, LV, Cederholm, T, Kolak, M, Halldin, M, et al.. Functional changes in adipose tissue in a randomised controlled trial of physical activity. Lipids Health Dis 2012;11:80. https:\/\/doi.org\/10.1186\/1476-511x-11-80.","DOI":"10.1186\/1476-511X-11-80"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_049","doi-asserted-by":"crossref","unstructured":"Chetty, VT, Damjanovic, S, Gerstein, H, Singh, N, Yusuf, S, Anand, SS, et al.. Metabolic effects of telmisartan in subjects with abdominal obesity: a prospective randomized controlled trial. Blood Press 2014;23:54\u201360. https:\/\/doi.org\/10.3109\/08037051.2013.791411.","DOI":"10.3109\/08037051.2013.791411"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_050","doi-asserted-by":"crossref","unstructured":"Srinivasa, S, Fitch, KV, Wong, K, Torriani, M, Mayhew, C, Stanley, T, et al.. RAAS activation is associated with visceral adiposity and insulin resistance among HIV-infected patients. J\u00a0Clin Endocrinol Metab 2015;100:2873\u201382. https:\/\/doi.org\/10.1210\/jc.2015-1461.","DOI":"10.1210\/jc.2015-1461"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_051","doi-asserted-by":"crossref","unstructured":"Lopez-Jaramillo, P, Lahera, V, Lopez-Lopez, J. Epidemic of cardiometabolic diseases: a Latin American point of view. Ther Adv Cardiovasc Dis 2011;5:119\u201331. https:\/\/doi.org\/10.1177\/1753944711403189.","DOI":"10.1177\/1753944711403189"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_052","doi-asserted-by":"crossref","unstructured":"Reimer, RA, Yamaguchi, H, Eller, LK, Lyon, MR, Gahler, RJ, Kacinik, V. Changes in visceral adiposity and serum cholesterol with a novel viscous polysaccharide in Japanese adults with abdominal obesity. Obesity [Internet n.d] https:\/\/doi.org\/10.1002\/oby.20435.","DOI":"10.1002\/oby.20435"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_053","doi-asserted-by":"crossref","unstructured":"Sofer, S, Eliraz, A, Kaplan, S, Voet, H, Fink, G, Kima, T, et al.. Greater weight loss and hormonal changes after 6\u00a0months diet with carbohydrates eaten mostly at dinner. Obesity 2011;19:2006\u201314. https:\/\/doi.org\/10.1038\/oby.2011.48.","DOI":"10.1038\/oby.2011.48"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_054","doi-asserted-by":"crossref","unstructured":"Takahira, M, Noda, K, Fukushima, M, Zhang, B, Mitsutake, R, Uehara, Y. Comparative trial of formula food containing soy protein vs. milk protein in visceral fat obesity\u00a0\u2013\u00a0FLAVO study. Circ J 2011;75:10\u20131253.","DOI":"10.1253\/circj.CJ-10-1013"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_055","doi-asserted-by":"crossref","unstructured":"Zhang, N, Chen, Y, Guo, X, Sun, G, Dai, D, Sun, Y. Metabolic abnormalities, but not metabolically healthy obesity, are associated with left ventricular hypertrophy. Heart Lung Circ 2017;26:251\u20137. https:\/\/doi.org\/10.1016\/j.hlc.2016.06.1212.","DOI":"10.1016\/j.hlc.2016.06.1212"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_056","doi-asserted-by":"crossref","unstructured":"Wani, K, Kumar, B, Al-Daghri, NM, Sabico, S. Exploring metabolic obesity phenotypes and atherosclerotic cardiovascular disease risk in Arab adults. Clin Obes 2025;15:e70032. https:\/\/doi.org\/10.1111\/cob.70032.","DOI":"10.1111\/cob.70032"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_057","doi-asserted-by":"crossref","unstructured":"Seo, Y-B, Kang, S-G, Song, S-W. Relationship between metabolically healthy obesity and coronary artery calcification. Obes Res Clin Pract 2024;18:28\u201334. https:\/\/doi.org\/10.1016\/j.orcp.2024.01.006.","DOI":"10.1016\/j.orcp.2024.01.006"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_058","doi-asserted-by":"crossref","unstructured":"Liu, X, Yang, C, Dang, Y, Chang, Z, Li, J, Zhao, Y, et al.. Risk of cardiovascular diseases among different metabolic obesity phenotypes: a prospective observational study. Metab Syndr Relat Disord 2023;21:306\u201313. https:\/\/doi.org\/10.1089\/met.2022.0100.","DOI":"10.1089\/met.2022.0100"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_059","doi-asserted-by":"crossref","unstructured":"Oh, C-M, Park, JH, Chung, HS, Yu, JM, Chung, W, Kang, JG, et al.. Effect of body shape on the development of cardiovascular disease in individuals with metabolically healthy obesity. Medicine 2020;99:e22036. https:\/\/doi.org\/10.1097\/MD.0000000000022036.","DOI":"10.1097\/MD.0000000000022036"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_060","doi-asserted-by":"crossref","unstructured":"Fan, J, Song, Y, Chen, Y, Hui, R, Zhang, W. Combined effect of obesity and cardio-metabolic abnormality on the risk of cardiovascular disease: a meta-analysis of prospective cohort studies. Int J Cardiol 2013;168:4761\u20138. https:\/\/doi.org\/10.1016\/j.ijcard.2013.07.230.","DOI":"10.1016\/j.ijcard.2013.07.230"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_061","doi-asserted-by":"crossref","unstructured":"Liu, X, Ling, J, Wu, Y, Zhao, H, Hu, Y, Yan, Z, et al.. Association between metabolically healthy obesity and atrial fibrillation: a systematic review and meta-analysis of longitudinal studies. Diabetes Metabol Syndr: Clin Res Rev 2025;19:103228. https:\/\/doi.org\/10.1016\/j.dsx.2025.103228.","DOI":"10.1016\/j.dsx.2025.103228"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_062","doi-asserted-by":"crossref","unstructured":"Bl\u00fcher, M. Metabolically healthy obesity. Endocr Rev 2020;41:bnaa004. https:\/\/doi.org\/10.1210\/endrev\/bnaa004.","DOI":"10.1210\/endrev\/bnaa004"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_063","doi-asserted-by":"crossref","unstructured":"Mongraw-Chaffin, M, Foster, MC, Anderson, CAM, Burke, GL, Haq, N, Kalyani, RR, et al.. Metabolically healthy obesity, transition to metabolic syndrome, and cardiovascular risk. J\u00a0Am Coll Cardiol 2018;71:1857\u201365. https:\/\/doi.org\/10.1016\/j.jacc.2018.02.055.","DOI":"10.1016\/j.jacc.2018.02.055"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_064","doi-asserted-by":"crossref","unstructured":"Gao, M, Lv, J, Yu, C, Guo, Y, Bian, Z, Yang, R, et al.. Metabolically healthy obesity, transition to unhealthy metabolic status, and vascular disease in Chinese adults: a cohort study. PLoS Med 2020;17:e1003351. https:\/\/doi.org\/10.1371\/journal.pmed.1003351.","DOI":"10.1371\/journal.pmed.1003351"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_065","doi-asserted-by":"crossref","unstructured":"Phillips, CM, Dillon, C, Harrington, JM, McCarthy, VJC, Kearney, PM, Fitzgerald, AP, et al.. Defining metabolically healthy obesity: role of dietary and lifestyle factors. PLoS One 2013;8:e76188. https:\/\/doi.org\/10.1371\/journal.pone.0076188.","DOI":"10.1371\/journal.pone.0076188"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_066","doi-asserted-by":"crossref","unstructured":"Stefan, N, H\u00e4ring, H-U, Hu, FB, Schulze, MB. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol 2013;1:152\u201362. https:\/\/doi.org\/10.1016\/S2213-8587(13)70062-7.","DOI":"10.1016\/S2213-8587(13)70062-7"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_067","doi-asserted-by":"crossref","unstructured":"Hotamisligil, GS, Shargill, NS, Spiegelman, BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87\u201391. https:\/\/doi.org\/10.1126\/science.7678183.","DOI":"10.1126\/science.7678183"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_068","doi-asserted-by":"crossref","unstructured":"Weisberg, SP, McCann, D, Desai, M, Rosenbaum, M, Leibel, RL, Ferrante, AWJr. Obesity is associated with macrophage accumulation in adipose tissue. J\u00a0Clin Investig 2003;112:1796\u2013808. https:\/\/doi.org\/10.1172\/JCI19246.","DOI":"10.1172\/JCI200319246"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_069","doi-asserted-by":"crossref","unstructured":"Antoniades, C, Shirodaria, C. Detecting coronary inflammation with perivascular fat attenuation imaging. JACC, Cardiovasc Imaging 2019;12:2011\u20134. https:\/\/doi.org\/10.1016\/j.jcmg.2018.12.024.","DOI":"10.1016\/j.jcmg.2018.12.024"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_070","doi-asserted-by":"crossref","unstructured":"Vandanmagsar, B, Youm, Y-H, Ravussin, A, Galgani, JE, Stadler, K, Mynatt, RL, et al.. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 2011;17:179\u201388. https:\/\/doi.org\/10.1038\/nm.2279.","DOI":"10.1038\/nm.2279"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_071","doi-asserted-by":"crossref","unstructured":"Esser, N, Legrand-Poels, S, Piette, J, Scheen, AJ, Paquot, N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract 2014;105:141\u201350. https:\/\/doi.org\/10.1016\/j.diabres.2014.04.006.","DOI":"10.1016\/j.diabres.2014.04.006"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_072","doi-asserted-by":"crossref","unstructured":"Oikonomou, EK, Williams, MC, Kotanidis, CP, Desai, MY, Marwan, M, Antonopoulos, AS, et al.. A novel machine learning-derived radiotranscriptomic signature of perivascular fat improves cardiac risk prediction using coronary CT angiography. Eur Heart J 2019;40:3529\u201343. https:\/\/doi.org\/10.1093\/eurheartj\/ehz592.","DOI":"10.1093\/eurheartj\/ehz592"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_073","doi-asserted-by":"crossref","unstructured":"Ghio, S, Acquaro, M, Agostoni, P, Ambrosio, G, Carluccio, E, Castiglione, V, et al.. Right heart failure in left heart disease: imaging, functional, and biochemical aspects of right ventricular dysfunction. Heart Fail Rev 2023;28:1009\u201322. https:\/\/doi.org\/10.1007\/s10741-022-10276-0.","DOI":"10.1007\/s10741-022-10276-0"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_074","doi-asserted-by":"crossref","unstructured":"Arnett, DK, Blumenthal, RS, Albert, MA, Buroker, AB, Goldberger, ZD, Hahn, EJ, et al.. 2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines. Circulation 2019;140:e596\u2013646. https:\/\/doi.org\/10.1161\/CIR.0000000000000678.","DOI":"10.1161\/CIR.0000000000000725"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_075","doi-asserted-by":"crossref","unstructured":"Ridker, PM. From CANTOS to CIRT to COLCOT to clinic: will all atherosclerosis patients soon be treated with combination lipid-lowering and inflammation-inhibiting agents? Circulation 2020;141:787\u20139. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.045256.","DOI":"10.1161\/CIRCULATIONAHA.119.045256"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_076","doi-asserted-by":"crossref","unstructured":"Mach, F, Baigent, C, Catapano, AL, Koskinas, KC, Casula, M, Badimon, L, et al.. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020;41:111\u201388. https:\/\/doi.org\/10.1093\/eurheartj\/ehz455.","DOI":"10.1093\/eurheartj\/ehz455"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_077","doi-asserted-by":"crossref","unstructured":"Johannesen, CDL, Mortensen, MB, Langsted, A, Nordestgaard, BG. Apolipoprotein B and non-HDL cholesterol better reflect residual risk than LDL cholesterol in statin-treated patients. J\u00a0Am Coll Cardiol 2021;77:1439\u201350. https:\/\/doi.org\/10.1016\/j.jacc.2021.01.027.","DOI":"10.1016\/j.jacc.2021.01.027"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_078","doi-asserted-by":"crossref","unstructured":"Dai, Y, Li, Y, Yang, S, Xu, W, Jia, H, Yang, C. Association between weight change and risk of metabolic abnormalities in non-overweight\/obese and overweight\/obese population: a retrospective cohort study among Chinese adults. Front Endocrinol 2022;13:1029941. https:\/\/doi.org\/10.3389\/fendo.2022.1029941.","DOI":"10.3389\/fendo.2022.1029941"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_079","doi-asserted-by":"crossref","unstructured":"Grundy, SM, Stone, NJ, Bailey, AL, Beam, C, Birtcher, KK, Blumenthal, RS, et al.. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines. Circulation 2019;139. https:\/\/doi.org\/10.1161\/CIR.0000000000000625.","DOI":"10.1161\/CIR.0000000000000698"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_080","doi-asserted-by":"crossref","unstructured":"Lin, JS, Evans, CV, Johnson, E, Redmond, N, Burda, BU, Coppola, EL, et al.. Nontraditional risk factors in cardiovascular disease risk assessment: a systematic evidence report for the U.S. preventive services task force [Internet] . Rockville (MD): Agency Healthc Res Qual (US); 2018, Report No.: 17-05225-EF-1.","DOI":"10.1001\/jama.2018.4242"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_081","doi-asserted-by":"crossref","unstructured":"Konieczna, J, Ya\u00f1ez, A, Mo\u00f1ino, M, Babio, N, Toledo, E, Mart\u00ednez-Gonz\u00e1lez, MA, et al.. Longitudinal changes in Mediterranean diet and transition between different obesity phenotypes. Clin Nutr 2020;39:966\u201375. https:\/\/doi.org\/10.1016\/j.clnu.2019.04.002.","DOI":"10.1016\/j.clnu.2019.04.002"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_082","doi-asserted-by":"crossref","unstructured":"Hamer, M, Stamatakis, E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J\u00a0Clin Endocrinol Metabol 2012;97:2482\u20138. https:\/\/doi.org\/10.1210\/jc.2011-3475.","DOI":"10.1210\/jc.2011-3475"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_083","doi-asserted-by":"crossref","unstructured":"Zembic, A, Eckel, N, Stefan, N, Baudry, J, Schulze, MB. An empirically derived definition of metabolically healthy obesity based on risk of\u00a0cardiovascular and total mortality. JAMA Netw Open 2021;4:e218505. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.8505.","DOI":"10.1001\/jamanetworkopen.2021.8505"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_084","doi-asserted-by":"crossref","unstructured":"Ma, L-Z, Sun, F-R, Wang, Z-T, Tan, L, Hou, X-H, Ou, Y-N, et al.. Metabolically healthy obesity and risk of stroke: a meta-analysis of prospective cohort studies. Ann Transl Med 2021;9:197. https:\/\/doi.org\/10.21037\/atm-20-4387.","DOI":"10.21037\/atm-20-4387"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_085","doi-asserted-by":"crossref","unstructured":"Chang, Y, Ryu, S, Choi, Y, Zhang, Y, Cho, J, Kwon, M-J, et al.. Metabolically healthy obesity and development of chronic kidney disease: a cohort study. Ann Intern Med 2016;164:305\u201312. https:\/\/doi.org\/10.7326\/M15-1323.","DOI":"10.7326\/M15-1323"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_086","doi-asserted-by":"crossref","unstructured":"Jung, CH, Lee, MJ, Kang, YM, Hwang, JY, Kim, EH, Park, J-Y, et al.. The risk of chronic kidney disease in a metabolically healthy obese population. Kidney Int 2015;88:843\u201350. https:\/\/doi.org\/10.1038\/ki.2015.183.","DOI":"10.1038\/ki.2015.183"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_087","doi-asserted-by":"crossref","unstructured":"Jae, SY, Franklin, B, Choi, Y-H, Fernhall, B. Metabolically healthy obesity and carotid intima-media thickness. Mayo Clin Proc 2015;90:1217\u201324. https:\/\/doi.org\/10.1016\/j.mayocp.2015.07.004.","DOI":"10.1016\/j.mayocp.2015.07.004"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_088","doi-asserted-by":"crossref","unstructured":"Itoh, H, Kaneko, H, Kiriyama, H, Yoshida, Y, Nakanishi, K, Mizuno, Y, et al.. Effect of metabolically healthy obesity on the development of carotid plaque in the general population: a community-based cohort study. JAT 2020;27:155\u201363. https:\/\/doi.org\/10.5551\/jat.48728.","DOI":"10.5551\/jat.48728"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_089","doi-asserted-by":"crossref","unstructured":"Phillips, CM. Metabolically healthy obesity: definitions, determinants and clinical implications. Rev Endocr Metab Disord 2013;14:219\u201327. https:\/\/doi.org\/10.1007\/s11154-013-9252-x.","DOI":"10.1007\/s11154-013-9252-x"},{"key":"2026102219020578949_j_jbcpp-2026-0266_ref_090","doi-asserted-by":"crossref","unstructured":"Lear, SA, Humphries, KH, Kohli, S, Chockalingam, A, Frohlich, JJ, Birmingham, CL. Visceral adipose tissue accumulation differs according to ethnic background: results of the multicultural community health assessment trial (M-CHAT). Am J Clin Nutr 2007;86:353\u20139. https:\/\/doi.org\/10.1093\/ajcn\/86.2.353.","DOI":"10.1093\/ajcn\/86.2.353"}],"container-title":["Journal of Basic and Clinical Physiology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2026-0266\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2026-0266\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:02:22Z","timestamp":1792695742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2026-0266\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":90,"alternative-id":["10.1515\/jbcpp-2026-0266"],"URL":"https:\/\/doi.org\/10.1515\/jbcpp-2026-0266","relation":{},"ISSN":["0792-6855","2191-0286"],"issn-type":[{"value":"0792-6855","type":"print"},{"value":"2191-0286","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]}}}